![]() The second area focuses on advanced castrate resistant and neuroendocrine disease, where Dr. Firstly, in the active surveillance population where developing signatures that could be clinically implemented to develop personalized protocols for follow-up and re-biopsy of such patients. His research focuses on characterizing novel molecular signatures and biomarkers to infer disease progression, targeting two clinical areas. He is also a consultant for genitourinary pathology and oncology cases for various department members. Bismar is a clinician scientist and urological pathologist working as primary pathologist for signing out genitourinary oncology cases. (Invasive Cardiologist)ĭepartment of Cardiology, Bilim University, Istanbul, R.T.Dr Bismar joined the BMC Cancer Senior Editorial Board in September 2020 and is currently a Professor at the University of Calgary and Adjunct Professor in the Department of Oncology at McGill University. School of Medicine, Ruprecht-Karls University, Heidelberg, GermanyĪttending Physician / Assoc. Ruprecht-Karls University, Heidelberg, Germany Herz- u.Diabeteszentrum, Bad Oeynhausen Herzzentrum Ludwigshafen and Klinikum Uelzen (Department of Cardiology / Department of Internal Medicine)ĭoctorate (PhD) (in the field of heart failure) Klinikum Uelzen, Germany (Coronary Intensive Care and Emergency Medicine Department)Ĭardiology and Internal Medicine Residency ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |